Trials In Focus
September 7, 2009 by admin
Filed under Media Reports, Media Reports 2009
| Novotech kicks off Dimebon trial Recruiting has begun for local sites in a Phase III international multi-centre study of the new Pfizer/Medivation Alzheimer’s hope Dimebon (Latrepirdine). CRO Novotech Which is running the CONCERT trial in Australia is looking to recruit patients with mild to moderate Alzheimer’s disease (AD) over eight sites, three in NSW, two in Victoria, and one each in Queenslan, South Australia, and Western Australia plus two New Zealand sites. |
For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1043  |
